Silver Spike Investment Corp. (SSIC)
USD 10.74
(1.27%)
USD 10.74
(1.27%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 7.34 Million USD | 2785.26% |
| 2022 | -273.34 Thousand USD | 51.48% |
| 2021 | -563.36 Thousand USD | 0.0% |
| 2020 | - USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 555.74 Million USD | 22149.75% |
| 2023 Q1 | 2.35 Million USD | 962.3% |
| 2023 Q4 | 2.49 Million USD | -99.91% |
| 2023 Q3 | 2.81 Billion USD | 1.02% |
| 2023 Q2 | 2.78 Billion USD | 118184.95% |
| 2023 FY | - USD | 2785.26% |
| 2022 Q2 | 211.73 Thousand USD | 100.0% |
| 2022 FY | - USD | 51.48% |
| 2022 Q4 | -273.34 Thousand USD | -148.82% |
| 2022 Q3 | 559.92 Thousand USD | 164.44% |
| 2022 Q1 | -563.36 Billion USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -150.1 Million USD | 104.89% |
| Theratechnologies Inc. | -10.31 Million USD | 171.175% |
| Safety Shot Inc | -12.18 Million USD | 160.238% |
| Cosmos Health Inc. | -17.06 Million USD | 143.021% |
| Cronos Group Inc. | -72.14 Million USD | 110.174% |
| Ironwood Pharmaceuticals, Inc. | -924.86 Million USD | 100.794% |
| Kala Pharmaceuticals, Inc. | -36.08 Million USD | 120.343% |
| Organogenesis Holdings Inc. | 36.03 Million USD | 79.628% |
| Universe Pharmaceuticals INC | -3.21 Million USD | 328.303% |
| ProPhase Labs, Inc. | -14.82 Million USD | 149.505% |
| Sonoma Pharmaceuticals, Inc. | -4.52 Million USD | 262.212% |
| Dynavax Technologies Corporation | 9.66 Million USD | 24.063% |
| Radius Health, Inc. | 38.31 Million USD | 80.84% |
| China SXT Pharmaceuticals, Inc. | -2.35 Million USD | 412.211% |
| Alvotech | -484.86 Million USD | 101.514% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 291.928% |
| Alpha Teknova, Inc. | -25.53 Million USD | 128.741% |
| Intra-Cellular Therapies, Inc. | -158.85 Million USD | 104.621% |
| SCYNEXIS, Inc. | 73.47 Million USD | 90.011% |
| Harrow Health, Inc. | 9.72 Million USD | 24.508% |
| Biofrontera Inc. | -18.45 Million USD | 139.777% |
| DURECT Corporation | -24.68 Million USD | 129.736% |
| Supernus Pharmaceuticals, Inc. | 98.26 Million USD | 92.53% |
| ANI Pharmaceuticals, Inc. | 109.32 Million USD | 93.286% |
| OptiNose, Inc. | -15.55 Million USD | 147.194% |
| RedHill Biopharma Ltd. | 26.26 Million USD | 72.055% |
| Aquestive Therapeutics, Inc. | 1.18 Million USD | -520.991% |
| Cumberland Pharmaceuticals Inc. | -710.85 Thousand USD | 1132.582% |
| SIGA Technologies, Inc. | 84.15 Million USD | 91.278% |
| Lifecore Biomedical, Inc. | 812 Thousand USD | -803.954% |
| Shineco, Inc. | -26.55 Million USD | 127.642% |
| Phibro Animal Health Corporation | 84.6 Million USD | 91.324% |
| Procaps Group S.A. | 104.02 Million USD | 92.944% |
| TherapeuticsMD, Inc. | -8.4 Million USD | 187.372% |
| Regencell Bioscience Holdings Limited | -3.61 Million USD | 302.898% |
| Viatris Inc. | 3.51 Billion USD | 99.791% |
| Sunshine Biopharma, Inc. | -3.82 Million USD | 291.928% |
| Rockwell Medical, Inc. | -4.69 Million USD | 256.372% |
| Incannex Healthcare Limited | -18.5 Million USD | 139.668% |
| Aytu BioPharma, Inc. | -1.01 Million USD | 825.307% |
| Tilray Brands, Inc. | -72.84 Million USD | 110.077% |
| Collegium Pharmaceutical, Inc. | 308.32 Million USD | 97.619% |
| PetIQ, Inc. | 81.48 Million USD | 90.992% |
| Neurocrine Biosciences, Inc. | 416.1 Million USD | 98.236% |
| Journey Medical Corporation | 1.92 Million USD | -282.098% |
| Alimera Sciences, Inc. | 7.27 Million USD | -0.881% |
| Petros Pharmaceuticals, Inc. | -4.21 Million USD | 274.272% |
| Assertio Holdings, Inc. | -222.44 Million USD | 103.3% |
| Shuttle Pharmaceuticals Holdings, Inc. | -3.99 Million USD | 283.933% |
| Embecta Corp. | 245.4 Million USD | 97.009% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 136.644% |
| Procaps Group, S.A. | 104.02 Million USD | 92.944% |
| PainReform Ltd. | -9.56 Million USD | 176.707% |
| Avadel Pharmaceuticals plc | -149.12 Million USD | 104.922% |
| Hempacco Co., Inc. | -12.77 Million USD | 157.465% |
| Talphera, Inc. | -9.84 Million USD | 174.579% |
| Pacira BioSciences, Inc. | 162.89 Million USD | 95.494% |
| Alvotech | -484.86 Million USD | 101.514% |
| Lantheus Holdings, Inc. | 491 Million USD | 98.505% |
| Kamada Ltd. | 21.53 Million USD | 65.914% |
| Indivior PLC | 66 Million USD | 88.879% |
| Currenc Group, Inc. | -1.9 Million USD | 486.205% |
| Evoke Pharma, Inc. | -7.29 Million USD | 200.656% |
| Flora Growth Corp. | -45.87 Million USD | 116.002% |
| Cyclo Therapeutics, Inc. | -20.03 Million USD | 136.644% |
| Evolus, Inc. | -41.81 Million USD | 117.556% |
| HUTCHMED (China) Limited | 25.52 Million USD | 71.247% |
| Amphastar Pharmaceuticals, Inc. | 241.46 Million USD | 96.96% |
| Akanda Corp. | -27.73 Million USD | 126.464% |